Invariant Sema5A inhibition serves an ensheathing function during optic nerve development.
Retinal axon pathfinding from the retina into the optic nerve involves the growth promoting axon guidance molecules L1, laminin and netrin 1, each of which governs axon behavior at specific regions along the retinal pathway. In identifying additional molecules regulating this process during embryonic mouse development, we found that transmembrane Semaphorin5A mRNA and protein was specifically expressed in neuroepithelial cells surrounding retinal axons at the optic disc and along the optic nerve. Given that growth cone responses to a specific guidance molecule can be altered by co-exposure to a second guidance cue, we examined whether retinal axon responses to Sema5A were modulated by other guidance signals axons encountered along the retinal pathway. In growth cone collapse, substratum choice and neurite outgrowth assays, Sema5A triggered an invariant inhibitory response in the context of L1, laminin, or netrin 1 signaling, suggesting that Sema5A inhibited retinal axons throughout their course at the optic disc and nerve. Antibody-perturbation studies in living embryo preparations showed that blocking of Sema5A function led to retinal axons straying out of the optic nerve bundle, indicating that Sema5A normally helped ensheath the retinal pathway. Thus, development of some CNS nerves requires inhibitory sheaths to maintain integrity. Furthermore, this function is accomplished using molecules such as Sema5A that exhibit conserved inhibitory responses in the presence of co-impinging signals from multiple families of guidance molecules.
Oster
Stephen F
SF
Department of Ophthalmology, Medical Scientist Training Program, University of California San Francisco, CA 94143, USA.
Bodeker
MacDara O
MO
He
Fengling
F
Sretavan
David W
DW
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology; D001369:Axons / Q000187:drug effects / Q000502:physiology; D018507:Gene Expression Regulation, Developmental; D020439:Growth Cones / Q000502:physiology; D066298:In Vitro Techniques; D007797:Laminin / Q000378:metabolism; D008565:Membrane Proteins / Q000235:genetics / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D009414:Nerve Growth Factors / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000235:genetics / Q000378:metabolism*; D000075388:Netrin-1; D009900:Optic Nerve / Q000196:embryology* / Q000502:physiology; D017434:Protein Structure, Tertiary; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012160:Retina / Q000187:drug effects / Q000196:embryology / Q000502:physiology; D039961:Semaphorins; D015398:Signal Transduction; D019699:Thrombospondins / Q000235:genetics / Q000378:metabolism; D025521:Tumor Suppressor Proteins
D000911:Antibodies, Monoclonal; D007797:Laminin; D008565:Membrane Proteins; D009414:Nerve Growth Factors; D009419:Nerve Tissue Proteins; C000617353:Ntn1 protein, mouse; D011994:Recombinant Proteins; C103619:Sema5A protein, mouse; D039961:Semaphorins; D019699:Thrombospondins; D025521:Tumor Suppressor Proteins; C121346:laminin 1; D000075388:Netrin-1